CDKN2C.md
... ...
@@ -14,11 +14,14 @@ nocite: |
14 14
15 15
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
16 16
17
-|Entity|source |frequency (%)|
18
-|:------:|:---------------------:|:-------------:|
19
-|BL |GAMBL genomes+capture|2.54 |
20
-|BL |Thomas cohort |3.40 |
21
-|BL |Panea cohort |3.00 |
17
+### BL
18
+[[include:tables/BL_CDKN2A.md]]
19
+
20
+### DLBCL
21
+[[include:tables/DLBCL_CDKN2A.md]]
22
+
23
+### FL
24
+[[include:tables/FL_CDKN2A.md]]
22 25
23 26
## Mutation pattern and selective pressure estimates
24 27
CHD4.md
... ...
@@ -14,11 +14,14 @@ nocite: |
14 14
15 15
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
16 16
17
-|Entity|source |frequency (%)|
18
-|:------:|:---------------------:|:-------------:|
19
-|BL |GAMBL genomes+capture|3.93 |
20
-|BL |Thomas cohort | NA |
21
-|BL |Panea cohort | NA |
17
+### BL
18
+[[include:tables/BL_CHD4.md]]
19
+
20
+### DLBCL
21
+[[include:tables/DLBCL_CHD4.md]]
22
+
23
+### FL
24
+[[include:tables/FL_CHD4.md]]
22 25
23 26
## Mutation pattern and selective pressure estimates
24 27
CPXM2.md
... ...
@@ -15,11 +15,15 @@ nocite: |
15 15
16 16
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
17 17
18
-|Entity|source |frequency (%)|
19
-|:------:|:---------------------:|:-------------:|
20
-|BL |GAMBL genomes+capture|1.85 |
21
-|BL |Thomas cohort | NA |
22
-|BL |Panea cohort | NA |
18
+### BL
19
+[[include:tables/BL_CIITA.md]]
20
+
21
+
22
+### DLBCL
23
+[[include:tables/DLBCL_CIITA.md]]
24
+
25
+### FL
26
+[[include:tables/FL_CIITA.md]]
23 27
24 28
## Mutation pattern and selective pressure estimates
25 29